Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - CHANGE IN WORKING CAPITAL
Change in Working Capital APLS - Apellis Pharmaceuticals, Inc.
-200 M
LAST VALUE
-46.30%
2 YEAR CAGR
-75.45%
5 YEAR CAGR
-96.06%
10 YEAR CAGR